Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Holmes

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
Communicable Diseases Intelligence (2018)|November 19, 2019
Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2018: the Influenza Complications Alert Network (FluCAN)Allen C Cheng, Mark Holmes, Dominic E Dwyer, et al.
Nature Ecology & Evolution|July 25, 2018
Gene exchange drives the ecological success of a multi-host bacterial pathogenEmily J Richardson, Rodrigo Bacigalupe, Ewan M Harrison, et al.
Communicable Diseases Intelligence (2018)|April 26, 2022
Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2019: the Influenza Complications Alert Network (FluCAN)Allen C Cheng, Dominic E Dwyer, Mark Holmes, et al.
Vaccine|August 4, 2011
Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control studyAllen C Cheng, Tom Kotsimbos, Heath A Kelly, et al.
Communicable Diseases Intelligence (2018)|April 6, 2022
Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN)Husna Begum, Dominic E Dwyer, Mark Holmes, et al.
The Lancet. Respiratory Medicine|December 6, 2016
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)Noel G McElvaney, Jonathan Burdon, Mark Holmes, et al.
American Journal of Respiratory and Critical Care Medicine|October 10, 2009
Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trialMario Castro, Adalberto S Rubin, Michel Laviolette, et al.
The Journal of Allergy and Clinical Immunology|September 4, 2013
Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthmaMichael E Wechsler, Michel Laviolette, Adalberto S Rubin, et al.
Nature Communications|December 2, 2025
Large-scale characterisation of the nasal microbiome redefines Staphylococcus aureus colonisation statusDinesh Aggarwal, Katherine L Bellis, Beth Blane, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Communicable Diseases Intelligence (2018)|November 19, 2019
Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2018: the Influenza Complications Alert Network (FluCAN)Allen C Cheng, Mark Holmes, Dominic E Dwyer, et al.
Nature Ecology & Evolution|July 25, 2018
Gene exchange drives the ecological success of a multi-host bacterial pathogenEmily J Richardson, Rodrigo Bacigalupe, Ewan M Harrison, et al.
Communicable Diseases Intelligence (2018)|April 26, 2022
Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2019: the Influenza Complications Alert Network (FluCAN)Allen C Cheng, Dominic E Dwyer, Mark Holmes, et al.
Vaccine|August 4, 2011
Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: a test-negative case control studyAllen C Cheng, Tom Kotsimbos, Heath A Kelly, et al.
Communicable Diseases Intelligence (2018)|April 6, 2022
Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN)Husna Begum, Dominic E Dwyer, Mark Holmes, et al.
The Lancet. Respiratory Medicine|December 6, 2016
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)Noel G McElvaney, Jonathan Burdon, Mark Holmes, et al.
American Journal of Respiratory and Critical Care Medicine|October 10, 2009
Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trialMario Castro, Adalberto S Rubin, Michel Laviolette, et al.
The Journal of Allergy and Clinical Immunology|September 4, 2013
Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthmaMichael E Wechsler, Michel Laviolette, Adalberto S Rubin, et al.
Nature Communications|December 2, 2025
Large-scale characterisation of the nasal microbiome redefines Staphylococcus aureus colonisation statusDinesh Aggarwal, Katherine L Bellis, Beth Blane, et al.
Pageof 20